Latest Articles

Open Access
Breast Cancer: Circular RNAs Mediating Efficacy in Preclinical In Vivo Models
ULRICH H. WEIDLE, HUNG-EN HSIA and ULRICH BRINKMANN

Cancer Genomics & Proteomics May 2023, 20 (3) 222-238; DOI: https://doi.org/10.21873/cgp.20377
Open Access
Biospecimen Digital Twins: Moving from a “High Quality” to a “Fit-for-Purpose” Concept in the Era of Omics Sciences
UMBERTO NANNI, PATRIZIA FERRONI, SILVIA RIONDINO, ANTONELLA SPILA, MARIA GIOVANNA VALENTE, GIROLAMO DEL MONTE, MARIO ROSELLI and FIORELLA GUADAGNI

Cancer Genomics & Proteomics May 2023, 20 (3) 211-221; DOI: https://doi.org/10.21873/cgp.20376
Open Access
Knockdown of G Protein-coupled Estrogen Receptor 1 (GPER1) Enhances Tumor-supportive Properties in Cervical Carcinoma Cells
SOPHIA RUCKRIEGL, JOHANNA LORIS, KATSIARYNA WERT, GERD BAUERSCHMITZ, JULIA GALLWAS and CARSTEN GRÜNDKER

Cancer Genomics & Proteomics May 2023, 20 (3) 281-297; DOI: https://doi.org/10.21873/cgp.20381
Open Access
The Role of Apoptotic Genes and Protein-Protein Interactions in Triple-negative Breast Cancer
GETINET M. ADINEW, SAMIA MESSEHA, EQUAR TAKA, SHADE A. AHMED and KARAM F.A. SOLIMAN

Cancer Genomics & Proteomics May 2023, 20 (3) 247-272; DOI: https://doi.org/10.21873/cgp.20379
Open Access
A Multiplex Biomarker Assay Improves the Prediction of Survival in Epithelial Ovarian Cancer
ARTURAS DOBILAS, ANNA ÅKESSON, PIA LEANDERSSON and CHRISTER BORGFELDT

Cancer Genomics & Proteomics May 2023, 20 (3) 273-280; DOI: https://doi.org/10.21873/cgp.20380
Open Access
Combination of Urinary MiR-501 and MiR-335 With Current Clinical Diagnostic Parameters as Potential Predictive Factors of Prostate Biopsy Outcome
JAROSLAV JURACEK, MARIE MADRZYK, KAROLINA TRACHTOVA, MICHAELA RUCKOVA, JULIA BOHOSOVA, DOMINIK A. BARTH, MARTIN PICHLER, MICHAL STANIK and ONDREJ SLABY

Cancer Genomics & Proteomics May 2023, 20 (3) 308-316; DOI: https://doi.org/10.21873/cgp.20383
Open Access
Loss of F-Box and Leucine Rich Repeat Protein 5 (FBXL5) Expression Is Associated With Poor Survival in Patients With Hepatocellular Carcinoma After Curative Resection: A Two-institute Study
YOON AH CHO, SUNG-EUN KIM, CHEOL KEUN PARK, HYUN HEE KOH, CHEOL-KEUN PARK and SANG YUN HA

Cancer Genomics & Proteomics May 2023, 20 (3) 298-307; DOI: https://doi.org/10.21873/cgp.20382
Open Access
A Bioinformatics Assessment Indicating Better Outcomes With Breast Cancer Resident, Immunoglobulin CDR3-MMP2 Binding
SUHAAS R. MANDALA, ALEXIS J. THOMSON, ETIENNE C. GOZLAN, DHRUV N. PATEL, ANDREA CHOBRUTSKIY, BORIS I. CHOBRUTSKIY and GEORGE BLANCK

Cancer Genomics & Proteomics May 2023, 20 (3) 239-246; DOI: https://doi.org/10.21873/cgp.20378
Open Access
An miRNA Signature Predicts Grading of Pancreatic Neuroendocrine Neoplasms
JAMES SALLER, DALEY WHITE, BROOKE HOUGH, SEAN YODER, JUNMIN WHITING, DUNG-TSA CHEN, ANTHONY MAGLIOCCO and DOMENICO COPPOLA

Cancer Genomics & Proteomics March 2023, 20 (2) 154-164; DOI: https://doi.org/10.21873/cgp.20370
Open Access
Up-regulated Circular RNAs in Colorectal Cancer: New Entities for Therapy and Tools for Identification of Therapeutic Targets
ULRICH H. WEIDLE and ADAM NOPORA

Cancer Genomics & Proteomics March 2023, 20 (2) 132-153; DOI: https://doi.org/10.21873/cgp.20369

Main menu

User menu

Search

Latest Articles

Pages